Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$40.1K Buy
231
+96
+71% +$17.3K 0.02% 240
2025
Q4
$25K Hold
135
0.01% 262
2025
Q3
$27.2K Sell
135
-40
-23% -$8.23K 0.01% 248
2025
Q2
$38.3K Buy
175
+40
+30% +$9.03K 0.02% 225
2025
Q1
$32.9K Hold
135
0.02% 170
2024
Q4
$28.7K Hold
135
0.02% 186
2024
Q3
$30.1K Hold
135
0.02% 178
2024
Q2
$28.4K Hold
135
0.02% 170
2024
Q1
$27.8K Hold
135
0.02% 171
2023
Q4
$25.6K Hold
135
0.02% 169
2023
Q3
$25.7K Hold
135
0.02% 167
2023
Q2
$25.4K Hold
135
0.02% 169
2023
Q1
$22.5K Hold
135
0.02% 162
2022
Q4
$22.3K Sell
135
-368
-73% -$60.2K 0.02% 173
2022
Q3
$75K Hold
503
0.07% 132
2022
Q2
$78K Hold
503
0.06% 147
2022
Q1
$86K Hold
503
0.06% 157
2021
Q4
$87K Hold
503
0.05% 171
2021
Q3
$76K Hold
503
0.04% 198
2021
Q2
$71K Hold
503
0.09% 195
2021
Q1
$61K Buy
+503
New +$57.9K 0.08% 194
2020
Q4
Sell
-368
Closed -$42K 160
2020
Q3
$42K Hold
368
0.09% 139
2020
Q2
$40K Hold
368
0.1% 125
2020
Q1
$32K Hold
368
0.12% 101
2019
Q4
$41K Buy
+368
New +$38.4K 0.08% 120

Other funds holding MRSH

Solstein Capital's MRSH Position: Q1 2026 in Review

Solstein Capital increased its Marsh (MRSH) stake by 71% in Q1 2026, buying an estimated $17.3K and bringing the position to 231 shares worth $40.1K. The position accounts for 0.02% of the portfolio, ranked #240.

Solstein Capital first reported a position in MRSH in Q4 2019 and has held it in 25 quarters since. The position peaked at $87K in Q4 2021. 1,534 funds tracked by Wall St. Rank hold MRSH as of Q1 2026.

  • Solstein Capital held 231 shares of Marsh worth $40.1K as of Q1 2026.
  • Solstein Capital bought 96 Marsh shares in Q1 2026, an estimated $17.3K.
  • Marsh made up 0.02% of Solstein Capital's portfolio in Q1 2026, its #240 holding.
  • Solstein Capital first reported a position in Marsh in Q4 2019 and has held it in 25 quarters since.
  • Solstein Capital's Marsh position peaked at $87K in Q4 2021.
  • 1,534 funds tracked by Wall St. Rank held Marsh as of Q1 2026.

Based on Solstein Capital's 13F filing for Q1 2026, filed 14 May 2026.